Oncompass Medicine is an AI-based medical software used to choose the right targeted cancer therapy for every patient.
Oncompass Medicine provide online software as a service decision support to oncologists to choose the right targeted therapy for their patients. With AI, they can compute more than 20,000 potential associations between cancer genes and targeted therapies in 20 milliseconds to predict each patient’s response to targeted therapies. It increases cancer patients’ chance to receive the right effective treatment, lower unnecessary costs and help pharma companies develop therapies faster and safer.
Learn more about Oncompass Medicine
What will you do if you win the Future Unicorn Award?
“If we win the Future Unicorn Award, we will reach out to IT companies and other digital health companies to develop our tool and combine the best digital solutions for cancer patients. We will also reach out to policymakers to accelerate the implementation of new technologies in European countries’ clinical practice.”
The Future Unicorn Award aims to highlight innovative start-ups and scale-ups that have the potential to become Europe’s next unicorns. The award is compiled by asking all the national trade associations affiliated with DIGITALEUROPE to nominate a single SME from their country. This results in a truly pan-European selection of incredible digital companies from all sectors.